Eduardo Burgarelli Lages

Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity

Eduardo Burgarelli Lages, Renata Salgado Fernandes, Juliana de Oliveira Silva et al. · Biomedicine & Pharmacotherapy · 2020 · 69 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations

Paula Rocha Chellini, Eduardo Burgarelli Lages, Pedro Franco et al. · Journal of AOAC International · 2015 · 48 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +11

Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

Cristiane Monteiro Pinto, Laila Sampaio Horta, Amanda P. Soares et al. · Pharmaceutics · 2021 · 26 citations · Full text

Pharmacy, Oncology, Pharmacology +17

pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects

Eduardo Burgarelli Lages, Renata Salgado Fernandes, Marina Mol Sena Andrade et al. · Biomedicine & Pharmacotherapy · 2021 · 16 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

4-Chlorophenylthioacetone-derived thiosemicarbazones as potent antitrypanosomal drug candidates: Investigations on the mode of action

Diego Rodney Rodrigues de Assis, Alexandre A. Oliveira, Samuel Porto et al. · Bioorganic Chemistry · 2021 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +5